Role of PARP Inhibition in Ovarian Cancer with Dr Thomas Herzog

Episode 149 · December 21st, 2022 · 49 mins 58 secs

About this Episode

Dr Thomas Herzog from the University of Cincinnati Medical Center in Cincinnati, Ohio, discusses updates and recent changes in the use of PARP inhibitors for ovarian cancer.

CME information and select publications here.